Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trialsSunil V. Badve, Vlado Perkovic|The Lancet Diabetes & Endocrinology|2024Cited by 247
Rationale and design of the Renal Lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney diseaseW Bakker, J W Rood, Sunil V. Badve et al.|Nephrology Dialysis Transplantation|2025Cited by 18